Apollo Medical Holdings, Inc. (NASDAQ:AMEH) Shares Bought by D.A. Davidson & CO.

Posted by on Apr 29th, 2023

D.A. Davidson & CO. boosted its position in shares of Apollo Medical Holdings, Inc. (NASDAQ:AMEH – Get Rating) by 1.9% in the fourth quarter, according to the company in its most recent filing with the SEC. The firm owned 29,795 shares of the company’s stock after acquiring an additional 548 shares during the quarter. D.A. Davidson & CO. owned about 0.05% of Apollo Medical worth $882,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds also recently added to or reduced their stakes in AMEH. JPMorgan Chase & Co. lifted its holdings in shares of Apollo Medical by 21.0% in the 1st quarter. JPMorgan Chase & Co. now owns 53,559 shares of the company’s stock valued at $2,596,000 after buying an additional 9,293 shares during the period. Citigroup Inc. lifted its holdings in shares of Apollo Medical by 12.9% in the 1st quarter. Citigroup Inc. now owns 32,729 shares of the company’s stock valued at $1,587,000 after buying an additional 3,734 shares during the period. PNC Financial Services Group Inc. lifted its holdings in shares of Apollo Medical by 49.9% in the 1st quarter. PNC Financial Services Group Inc. now owns 1,563 shares of the company’s stock valued at $75,000 after buying an additional 520 shares during the period. MetLife Investment Management LLC lifted its holdings in shares of Apollo Medical by 53.6% in the 1st quarter. MetLife Investment Management LLC now owns 20,211 shares of the company’s stock valued at $980,000 after buying an additional 7,056 shares during the period. Finally, Rhumbline Advisers lifted its holdings in shares of Apollo Medical by 7.5% in the 1st quarter. Rhumbline Advisers now owns 92,806 shares of the company’s stock valued at $4,498,000 after buying an additional 6,484 shares during the period. Institutional investors and hedge funds own 34.91% of the company’s stock.

Apollo Medical Stock Performance

NASDAQ AMEH opened at $35.49 on Friday. The stock has a market capitalization of $2.04 billion, a price-to-earnings ratio of 34.04, a PEG ratio of 1.91 and a beta of 0.73. Apollo Medical Holdings, Inc. has a twelve month low of $26.89 and a twelve month high of $58.00. The company has a current ratio of 2.95, a quick ratio of 2.95 and a debt-to-equity ratio of 0.37. The stock has a 50-day moving average of $37.10 and a 200 day moving average of $33.95.

Apollo Medical (NASDAQ:AMEH – Get Rating) last released its quarterly earnings results on Thursday, February 23rd. The company reported $0.02 earnings per share for the quarter, missing analysts’ consensus estimates of $0.09 by ($0.07). Apollo Medical had a return on equity of 10.37% and a net margin of 4.29%. The business had revenue of $294.21 million during the quarter, compared to analyst estimates of $264.40 million. Sell-side analysts anticipate that Apollo Medical Holdings, Inc. will post 1.14 EPS for the current fiscal year.

Analyst Ratings Changes

AMEH has been the subject of several analyst reports. Lake Street Capital boosted their price objective on Apollo Medical from $40.00 to $60.00 and gave the company a “buy” rating in a report on Monday, February 27th. Bank of America initiated coverage on Apollo Medical in a report on Wednesday, April 12th. They issued a “neutral” rating and a $44.00 price target for the company.

Apollo Medical Company Profile

(Get Rating)

Apollo Medical Holdings, Inc is a physician-centric, technology-powered, risk-bearing healthcare management company, which engages in the provision of care coordination services and a healthcare delivery platform. The company was founded on November 1, 1985 and is headquartered in Alhambra, CA.

See Also

Institutional Ownership by Quarter for Apollo Medical (NASDAQ:AMEH)

Receive News & Ratings for Apollo Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Apollo Medical and related companies with MarketBeat.com's FREE daily email newsletter.